New
Radiation Plus Combination Immunotherapy May Help Preserve Bladder In Some Patients With Muscle-invasive Bladder Cancer
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses that allowed for bladder preservation, according to new results.
